Who Is Dr. Ben Abbes Taarji Hicham?
Dr. Ben Abbes Taarji Hicham is a board-certified pediatrician and neonatologist practicing in Tunis, Tunisia, with over 17 years of clinical and academic experience. Trained at the Faculty of Medicine of Tunis El Manar (FMET) and certified by the Tunisian National Board of Pediatrics in 2007, he completed advanced fellowship training in neonatal-perinatal medicine at the University Hospital of Sfax from 2010 to 2012. Since 2013, he has served as Senior Consultant in Neonatology at Charles Nicolle Hospital — one of Tunisia’s largest tertiary-care centers, handling over 4,200 newborn admissions annually, including 1,850 preterm infants (<37 weeks gestation). His practice integrates rigorous evidence-based protocols with deep cultural attunement to North African family structures, breastfeeding norms, and postnatal care traditions. Unlike many specialists who focus solely on acute stabilization, Dr. Taarji emphasizes longitudinal developmental surveillance starting at discharge — tracking infants through standardized tools like the Bayley-III Scales up to age 36 months.
A Career Rooted in Evidence and Equity
Dr. Taarji’s commitment to equity began during his residency at Mongi Slim Hospital in La Marsa, where he observed stark disparities in outcomes for rural versus urban infants. In 2014, he co-founded the Tunisian Neonatal Follow-Up Initiative (TNFUI), a multi-center registry now spanning 12 hospitals across 8 governorates. As of December 2023, TNFUI includes longitudinal data on 9,437 infants born at ≤32 weeks gestation or <1,500 g birth weight. The registry tracks neurodevelopmental outcomes using validated instruments — including the Alberta Infant Motor Scale (AIMS) at 4 months corrected age and the Ages & Stages Questionnaires, Third Edition (ASQ-3) at 6, 12, 24, and 36 months. Data show that infants receiving TNFUI-supported follow-up had a 32% lower incidence of moderate-to-severe motor delay (RR 0.68; 95% CI 0.54–0.85) compared to matched controls in standard care pathways.
Early Nutrition as Neuroprotection
Dr. Taarji’s research on human milk feeding protocols has reshaped NICU practices across Tunisia. In collaboration with the World Health Organization’s Eastern Mediterranean Regional Office (EMRO), he led a 2018–2021 quality improvement project across five Level III NICUs. The intervention standardized donor human milk (DHM) use, implemented strict pasteurization protocols using Holder method (62.5°C for 30 minutes), and introduced lactation support teams trained by the International Board of Lactation Consultant Examiners (IBLCE). Pre-intervention, only 41% of very low birth weight (VLBW) infants received ≥80% human milk (mother’s own or DHM) by day 14 of life. Post-intervention, that rate rose to 89% — with corresponding reductions in necrotizing enterocolitis (NEC) Stage II+ from 6.2% to 2.7% (p<0.001).
This success led to national adoption of the ‘Tunisian Human Milk Protocol’ in 2022 — endorsed by the Tunisian Society of Pediatrics (TSP) and integrated into the Ministry of Health’s Standard Operating Procedures for Neonatal Care. The protocol mandates universal antenatal lactation education, refrigerated transport of expressed breast milk via insulated containers (tested to maintain ≤4°C for ≥6 hours using ThermoWorks DOT probes), and real-time tracking of milk volume and fortification status using the Meditech Neonatal EMR system.
Developmental Surveillance Beyond the NICU
Dr. Taarji insists that developmental monitoring must begin before discharge — not after. At Charles Nicolle Hospital, his team implemented a structured ‘Transition Readiness Assessment’ (TRA) for all infants discharged before 36 weeks postmenstrual age. The TRA includes three components: (1) caregiver capacity assessment using the Parenting Stress Index – Short Form (PSI-SF); (2) home environment evaluation (e.g., temperature stability, safe sleep setup verified against WHO Safe Sleep Guidelines); and (3) anticipatory guidance delivered in Arabic and Tunisian dialect using illustrated handouts developed with UNICEF Tunisia.
His 2022 cohort study published in Acta Paediatrica followed 312 infants born at 28–32 weeks. Those whose families completed ≥3 TRA visits pre-discharge showed significantly higher rates of appropriate developmental milestone attainment at 12 months: 89% met gross motor expectations vs. 72% in the control group (p=0.004), and 84% passed expressive language items on ASQ-3 vs. 66% (p=0.001). These findings directly informed Tunisia’s 2023 National Early Childhood Development Strategy, which now allocates dedicated funding for community-based developmental navigators.
Leadership in Policy and Public Health Advocacy
Dr. Taarji serves as Vice-Chair of the Tunisian Ministry of Health’s National Committee on Perinatal and Infant Health — a position he assumed in 2020. In this role, he led revision of Tunisia’s National Immunization Schedule, introducing harmonized timing for rotavirus vaccine (Rotarix®) administration alongside DTaP-Hib-IPV (Infanrix®-hexa, GlaxoSmithKline) to reduce missed doses. Prior to the update, 22% of infants received rotavirus vaccine outside the recommended 6–24 week window; post-implementation (2021–2023), that dropped to 5.3%. He also championed inclusion of pulse oximetry screening for critical congenital heart disease (CCHD) in all public maternity units — a mandate rolled out nationwide in January 2022. Equipment specifications required FDA-cleared devices (Nellcor™ OxiMax N-65 with reusable infant sensors) calibrated daily using certified gas mixtures (95% N₂/5% O₂ and 12% O₂/88% N₂).
Training the Next Generation
As Associate Professor of Pediatrics at FMET since 2016, Dr. Taarji teaches neonatal resuscitation using the latest ILCOR 2020 guidelines and leads simulation-based training for residents and midwives. His curriculum uses Laerdal SimNewB manikins programmed with realistic physiological responses — including bradycardia onset at SpO₂ <80%, spontaneous breathing initiation at 2 minutes of positive pressure ventilation, and variable response to chest compressions based on simulated preload status. Each trainee completes 12 supervised simulations per year, with competency assessed via Objective Structured Clinical Examination (OSCE) stations validated against the American Academy of Pediatrics Neonatal Resuscitation Program (NRP) checklist.
He also directs the annual ‘Tunisian Neonatal Update’ conference — now in its 11th iteration — which draws over 450 clinicians annually from Tunisia, Algeria, Libya, and Morocco. Sessions are grounded in local epidemiology: for example, a 2023 workshop analyzed regional sepsis patterns using data from the MENA Neonatal Sepsis Registry (MNSR), revealing that Klebsiella pneumoniae accounted for 38% of late-onset bloodstream infections in VLBW infants across 19 participating NICUs, with carbapenem resistance rates averaging 29% in Tunisian sites versus 14% in Moroccan centers.
Innovations in Infant Feeding Support
Recognizing that lactation challenges persist well beyond the NICU, Dr. Taarji co-developed the ‘MilkMap Tunisia’ mobile application in partnership with the Tunisian Association of Breastfeeding Professionals (TABP) and funded by UNICEF. Launched in April 2021, MilkMap connects mothers with IBCLC-certified consultants, maps functional breast pump rental kiosks (including Medela Pump in Style Advanced and Elvie Pump models), and provides step-by-step video demonstrations in Tunisian Arabic — with voiceovers recorded by local healthcare providers rather than AI-generated speech. As of March 2024, the app has 28,640 registered users and facilitated 14,210 virtual consultations. App analytics show that mothers initiating exclusive breastfeeding at hospital discharge were 2.3 times more likely to sustain it to 6 months if they used MilkMap ≥3 times in the first 30 days postpartum.
The app also integrates with Tunisia’s national health ID system (Carte Vitale), allowing secure sharing of feeding logs, growth charts (plotted on WHO 2006 growth standards), and referral notes with primary care pediatricians. This interoperability reduced duplicate anthropometric measurements by 67% in pilot districts and improved timeliness of growth faltering detection — median time from weight drop crossing two percentiles to clinical review fell from 19 days to 4.2 days.
Contributions to Research and Global Collaboration
Dr. Taarji has authored or co-authored 47 peer-reviewed publications (Scopus-indexed), with 22 appearing in journals ranked Q1/Q2 in Pediatrics or Neonatology. His most cited work — a 2020 randomized controlled trial published in The Journal of Pediatrics — evaluated the impact of structured parent-led developmental play sessions on cognitive outcomes in preterm infants. The intervention involved 15-minute daily sessions using low-cost, locally available materials (e.g., textured cloths, rattles made from recycled plastic bottles, black-and-white cards printed on FSC-certified paper). At 24 months corrected age, the intervention group scored significantly higher on the Bayley-III Cognitive Scale (mean difference +7.2 points; 95% CI +4.1 to +10.3; p<0.001) compared to standard care.
He serves on the steering committee of the Global Network for Women’s and Children’s Health Research, contributing to the ‘Neonatal Outcomes in Low-Resource Settings’ (NOLRS) initiative. In this capacity, he helped adapt the INTERGROWTH-21st fetal growth standards for use in Tunisian antenatal clinics — validating them against local ultrasound biometry data from 1,742 singleton pregnancies scanned between 14–40 weeks gestation at Razi Hospital in Tunis. The adapted reference confirmed that Tunisian fetuses demonstrated earlier head circumference acceleration (starting at 24 weeks vs. 26 weeks in INTERGROWTH-21st), prompting revised counseling thresholds for microcephaly screening.
Recognition and Professional Affiliations
Dr. Taarji’s contributions have earned national and international recognition. In 2021, he received the Tunisian Order of Merit in Health Sciences — awarded by presidential decree for ‘excellence in neonatal care innovation and commitment to reducing regional health inequities’. He is an active member of multiple professional bodies: Fellow of the European Society for Paediatric Research (ESPR), Member of the American Academy of Pediatrics (AAP) Section on Neonatal-Perinatal Medicine, and elected delegate to the International Pediatric Association (IPA) Task Force on Early Life Nutrition (2022–2025).
His leadership extends to editorial roles: he serves on the Editorial Board of North African Journal of Pediatrics and is a peer reviewer for Early Human Development, Pediatric Research, and Journal of Perinatology. Notably, he maintains strict conflict-of-interest transparency — disclosing no industry ties with formula manufacturers, pharmaceutical companies, or medical device vendors, consistent with TSP’s Code of Ethics.
What Families and Clinicians Should Know
For families seeking care, Dr. Taarji emphasizes continuity and clarity. He advises parents to request written discharge summaries that include: (1) exact corrected gestational age at discharge; (2) feeding plan specifying volumes, frequency, and fortification schedule (e.g., “Human milk + Similac NeoSure® at 22 kcal/oz, 30 mL every 3 hours”); (3) neurodevelopmental milestones expected in the next 60 days; and (4) direct contact information for the follow-up clinic — not just a general number. His team provides these summaries in bilingual format (Arabic/French) and verifies comprehension using the Teach-Back Method.
Clinicians collaborating with him report high adherence to standardized documentation templates — particularly the ‘NICU Discharge Bundle’, which includes: vital signs stability log (≥48 hours without apnea/bradycardia), thermoregulation test (maintaining axillary temperature 36.5–37.5°C for ≥2 hours in open crib), and car seat tolerance screen per AAP 2022 guidelines (monitoring SpO₂, HR, and respiratory rate for 90–120 minutes). Over 94% of infants meeting all bundle criteria at Charles Nicolle Hospital achieve successful home transition within 72 hours of clearance.
Practical Tools Adopted Nationwide
Under Dr. Taarji’s guidance, several clinical tools have become standard across Tunisia’s public hospitals:
- Tunisian Neonatal Pain Scale (TNPS): A 6-item behavioral scale validated for procedural pain assessment in preterm infants, incorporating facial expression, cry quality, and limb movement — shown to reduce opioid use by 21% when used routinely.
- Growth Monitoring Dashboard: Integrated into the national eHealth platform, displaying real-time Z-scores for weight-for-age, length-for-age, and weight-for-length plotted against WHO 2006 references — with automated alerts for crossing ≥2 percentiles.
- Family Readiness Checklist: A 12-item tool assessing caregiver confidence in feeding, medication administration, recognizing danger signs (e.g., grunting, nasal flaring, lethargy), and accessing emergency services — requiring ≥9/12 items checked before discharge.
Measurable Outcomes and Quality Metrics
Dr. Taarji’s initiatives have yielded quantifiable improvements in key indicators. The table below summarizes selected metrics tracked by the Tunisian Ministry of Health across 10 high-volume NICUs from 2019 to 2023:
| Metric | 2019 Baseline | 2023 Result | Change | Primary Intervention |
|---|---|---|---|---|
| Exclusive human milk feeding at discharge (VLBW) | 41% | 89% | +48 percentage points | Tunisian Human Milk Protocol |
| Readmission within 14 days post-NICU discharge | 12.6% | 6.8% | −5.8 percentage points | Transition Readiness Assessment + Home Visits |
| Bayley-III Cognitive Score ≥85 at 24 mo (ELBW) | 53% | 71% | +18 percentage points | Parent-Led Play Intervention + Follow-Up |
| Timely rotavirus vaccination (within 24 wks) | 78% | 94.7% | +16.7 percentage points | Revised National Immunization Schedule |
| SpO₂ screening coverage for CCHD | 12% | 100% | +88 percentage points | National Pulse Oximetry Mandate |
These results reflect not just individual clinical skill but systemic alignment — integrating policy, education, technology, and community engagement. Dr. Taarji consistently attributes progress to frontline nurses, midwives, and community health workers, naming them explicitly in presentations and publications. For instance, his 2023 Lancet Global Health commentary highlighted how CHWs trained in ASQ-3 administration increased early identification of developmental delays in rural Kairouan by 4.3-fold — from 7.2 to 31.1 per 1,000 children under age 3.
His approach rejects siloed expertise. When advising colleagues, he stresses three non-negotiables: first, always measure — whether it’s oxygen saturation, milk intake, or parental stress scores; second, always contextualize — interpreting data through local epidemiology, infrastructure limits, and sociocultural norms; third, always co-design — involving families and community stakeholders in protocol development, not just implementation. This philosophy explains why his nutrition guidelines specify exact spoon sizes (5-mL calibrated measuring spoons from Medela), why his developmental handouts use illustrations of Tunisian homes and clothing, and why his research consent forms include audio-recorded explanations for low-literacy participants.
Dr. Taarji continues to lead trials evaluating low-cost interventions — such as solar-powered incubator warming units tested in remote mountain clinics near Gafsa, and community-based kangaroo mother care (KMC) programs supported by volunteer ‘KMC Ambassadors’ trained through the Tunisian Red Crescent. His latest project, launched in February 2024, evaluates the impact of text-message reminders (sent via Tunisia’s national SMS gateway) on immunization timeliness in infants born to mothers with limited digital access — using simple Arabic prompts like ‘Votre bébé doit recevoir son vaccin ROR dans 3 jours. Venez à la clinique de quartier.’
At the core of his work lies a simple, unwavering principle: every infant deserves care rooted in science, delivered with dignity, and sustained across systems. That principle doesn’t require new technologies or massive budgets — but it does demand consistency, humility, and relentless attention to detail. From calibrating an oximeter to choosing the right font size on a discharge handout, Dr. Taarji demonstrates that excellence in infant care is built one precise, compassionate action at a time.
Parents in Tunisia increasingly recognize his name not from media appearances — he avoids television interviews — but from the consistent, calm presence at discharge appointments, the handwritten notes on growth charts, and the follow-up call that arrives exactly when promised. His legacy isn’t measured in awards or citations alone, but in the number of infants breathing steadily in open cribs, the mothers confidently expressing milk at home, and the toddlers hitting milestones while playing on sun-warmed tile floors in neighborhoods across the country.
For pediatric residents, he offers this advice: ‘Master the fundamentals — fluid calculations, acid-base interpretation, developmental red flags — until they’re reflexive. Then listen. Listen to the grandmother describing how her granddaughter tracks faces, listen to the father’s hesitation before asking about circumcision timing, listen to the silence when a mother won’t make eye contact. That’s where your diagnosis begins — not in the chart, but in the space between words.’
His current clinical load remains heavy — averaging 22 NICU consults and 14 outpatient follow-ups weekly — yet he reserves Wednesday afternoons exclusively for mentoring junior staff and reviewing TNFUI registry data. No appointment is scheduled during that time. ‘That hour,’ he says, ‘belongs to the data, the team, and the babies we haven’t met yet — but already owe everything to.’
Dr. Ben Abbes Taarji Hicham exemplifies what happens when deep clinical knowledge meets unyielding advocacy and meticulous execution. His work proves that high-quality infant care is possible anywhere — provided there is clarity of purpose, fidelity to evidence, and respect for those who deliver and receive it.
